Visit https://www.peervoice.com/KPU860 to view the entire programme with slides. After completing “Christine Simmons, MD, MSc, FRCPC - Managing HR+/HER2- Metastatic Breast Cancer in the Community: Optimizing Safety to Maximize Benefit”, participants will be able to: Explain the need to factor cardiovascular (CV) health into management decisions for patients with HR+/HER2- metastatic breast cancer (mBC); Outline best practices, from a cardio-oncology perspective, to reduce CV risk in patients with HR+/HER2- mBC receiving CDK4/6 inhibitors; Discuss key challenges in the management of older adults with HR+/HER2- mBC; and Implement practical, geriatric-oncology strategies to treat older adults with HR+/HER2- mBC in accordance to their health and preferences.